CPT® Code 88384

Deleted

1. Indications

The procedure associated with CPT® Code 88384 is indicated for various clinical scenarios where the evaluation of nucleic acid molecules is necessary. The following conditions may warrant the use of this code:

• Genetic Testing The assessment of genetic material to identify mutations or variations that may contribute to hereditary conditions or predispositions to certain diseases.
• Oncology The evaluation of tumor samples to detect specific genetic alterations that can inform treatment options and prognostic outcomes.
• Infectious Diseases The identification of pathogens through the analysis of nucleic acids, aiding in the diagnosis and management of infectious diseases.
• Pharmacogenomics The study of how genes affect a person's response to drugs, which can guide personalized medicine approaches.

2. Procedure

The procedure for CPT® Code 88384 involves several key steps that ensure accurate evaluation of the nucleic acid molecules using multiple probes. The following procedural steps are typically included:

• Step 1: Sample Collection A biological sample, such as blood, tissue, or other bodily fluids, is collected from the patient. This sample serves as the source of nucleic acids for analysis.
• Step 2: Nucleic Acid Extraction The nucleic acids (DNA or RNA) are extracted from the collected sample using specialized techniques that isolate the genetic material while removing contaminants.
• Step 3: Probe Hybridization The extracted nucleic acids are then subjected to hybridization with the selected molecular probes. In this case, between 11 and 50 probes are utilized, each designed to bind to specific sequences of interest within the nucleic acids.
• Step 4: Detection and Analysis After hybridization, the bound probes are detected using various methods, such as fluorescence or colorimetric assays. The results are analyzed to identify the presence or absence of specific genetic sequences.
• Step 5: Interpretation of Results The data obtained from the analysis is interpreted by qualified professionals, who assess the significance of the findings in the context of the patient's clinical situation.

3. Post-Procedure

Following the array-based evaluation associated with CPT® Code 88384, several post-procedure considerations are important. The results of the nucleic acid analysis are typically compiled into a report that is reviewed by the healthcare provider. This report may include interpretations of the findings, recommendations for further testing, or potential treatment options based on the genetic information obtained. Patients may be advised on follow-up appointments to discuss the results and any necessary next steps in their care. Additionally, it is essential to ensure that the results are documented accurately in the patient's medical record for future reference and continuity of care.